Isolation of human antigen-specific regulatory T cells with high suppressive function

European Journal of Immunology

Volumn 44, Issue 9, 2014, Pages 2592-2602

  Noyan, Fatih ^a   Lee, Young Seon ^a   Zimmermann, Katharina ^a   Hardtke Wolenski, Matthias ^a   Taubert, Richard ^a   Warnecke, Gregor ^a   Knoefel, Ann Kathrin ^a   Schulde, Elvira ^a   Olek, Sven ^b   Manns, Michael P ^a   Jaeckel, Elmar ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b EPIONTIS GMBH   (Germany)

Author keywords

Antigen specific; CD154; GARP; LAP; Regulatory T (Treg) cells

Indexed keywords

LEUKOCYTE ANTIGEN;

ANIMAL; ANTIGEN-SPECIFIC; ARTICLE; CD154; CELL SEPARATION; CLINICAL TRIAL; CYTOLOGY; FEMALE; GARP; GENETIC EPIGENESIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; LAP; MALE; MOUSE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; REGULATORY T (TREG) CELLS; REGULATORY T LYMPHOCYTE;

ANTIGEN-SPECIFIC; CD154; GARP; LAP; REGULATORY T (TREG) CELLS;

ANIMALS; ANTIGENS, CD; CELL SEPARATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 84907821782     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344381     Document Type: Article

References (42)

1. Meier-Kriesche, H.-U., Schold, J. D. and Kaplan, B., Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am. J. Transplant. 2004. 4: 1289- 1295.
2. Graca, L., Thompson, S., Lin, C.-Y., Adams, E., Cobbold, S. P. and Waldmann, H., Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J. Immunol. 2002. 168: 5558-5565.
3. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004. 22: 531-562.
4. + regulatory T lymphocytes. Nat. Med. 2008. 14: 88-92.
5. + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/ differentiation of pathogenic T cells. J. Immunol. 2006. 176: 1266-1273.
6. + regulatory T cells preserve graft-versustumor activity while inhibiting graft-versus-host disease after bonemarrow transplantation. Nat. Med. 2003. 9: 1144-1150.
7. Wood, K. J. and Sakaguchi, S., Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 2003. 3: 199-210.
8. Issa, F., Hester, J., Goto, R., Nadig, S. N., Goodacre, T. E. and Wood, K., Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 2010. 90: 1321- 1327.
9. Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., Defor, T. et al., Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011. 117: 1061-1070.
10. +CD127- T regulatory cells. Clin. Immunol. 2009. 133: 22-26.
11. Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B. et al., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011. 117: 3921-3928.
12. Edinger, M. and Hoffmann, P., Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr. Opin. Immunol. 2011. 23: 679-684.
13. Leslie, M., Immunology. Regulatory T cells get their chance to shine. Science 2011. 332: 1020-1021.
14. Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L. et al., In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 1455-1465.
15. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. USA 2006. 103: 2758-2763.
16. + regulatory T cell function in alloimmunity. J. Immunol. 2006. 176: 329-334.
17. Jaeckel, E., von Boehmer, H. and Manns, M. P., Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005. 54: 306-310.
18. Peters, J. H., Preijers, F. W., Woestenenk, R., Hilbrands, L. B., Koenen, H. J. P. M. and Joosten, I., Clinical grade Treg: GMP isolation, improvement of purity by CD127pos depletion, Treg expansion, and Treg cryopreservation. PLoS One 2008. 3: e3161.
19. + T cells. Eur. J. Immunol. 2007. 37: 129-138.
20. + Treg cells. J. Exp. Med. 2006. 203: 1701-1711.
21. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 1693-1700.
22. Putnam, A. L., Brusko, T. M., Lee, M. R., Liu, W., Szot, G. L., Ghosh, T., Atkinson, M. A. et al., Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009. 58: 652-662.
23. Tran, D. Q., Andersson, J., Hardwick, D., Bebris, L., Illei, G. G. and Shevach, E. M., Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood 2009. 113: 5125-5133.
24. + regulatory T cells. Proc. Natl. Acad. Sci. USA 2009. 106: 13445-13450.
25. + Treg. J. Immunol. 2012. 189: 5985-5994.
26. + T cells specific for defined antigens according to CD154 expression. Nat. Med. 2005. 11: 1118-1124.
27. + natural regulatory T cells. J. Immunol. 2012. 188: 1083-1090.
28. Mallone, R., Mannering, S. I., Brooks-Worrell, B. M., Durinovic-Bello, I., Cilio, C. M., Wong, F. S. and Schloot, N. C., Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin. Exp. Immunol. 2011. 163: 33-49.
29. Sagoo, P., Ali, N., Garg, G., Nestle, F. O., Lechler, R. I. and Lombardi, G., Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 2011. 3: 83ra42-83ra42.
30. Hartwig, U. F., Nonn, M., Khan, S., Meyer, R. G., Huber, C. and Herr, W., Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes. Bone Marrow Transplant 2006. 37: 297-305.
31. + regulatory T cells for clinical trials. Biol. Blood Marrow Transplant 2006. 12: 267-274.
32. Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Del Papa, B., Perruccio, K., Ruggeri, L. et al., Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. Best Pract. Res. Clin. Haematol. 2011. 24: 459-466.
33. + T cells. Eur. J. Immunol. 2007. 37: 129-138.
34. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 2983-2990.
35. Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H. J., Waldmann, H., Huehn, J. et al., Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012. 36: 262-275.
36. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grutzkau, A., Dong, J., Thiel, A. et al., DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007. 37: 2378-2389.
37. Polansky, J. K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., Olek, S. et al., DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 2008. 38: 1654-1663.
38. Hippen, K. L., Riley, J. L., June, C. H.andBlazar, B. R., Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 2011. 23: 462-468.
39. + regulatory T cell treatment for the induction of donor-specific transplantation tolerance. Int. Immunopharmacol. 2006. 6: 1879-1882.
40. Issa, F., Hester, J., Goto, R., Nadig, S. N., Goodacre, T. E. and Wood, K., Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 2010. 90: 1321- 1327.
41. Putnam, A. L., Safinia, N., Medvec, A., Laszkowska, M., Wray, M., Mintz, M. A., Trotta, E. et al., Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am. J. Transplant. 2013. 13: 3010-3020.
42. Sehouli, J., Loddenkemper, C., Cornu, T., Schwachula, T., Hoffmuller, U., Grutzkau, A., Lohneis, P. et al., Epigenetic quantification of tumorinfiltrating T-lymphocytes. Epigenetics 2011. 6: 236-246.